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Background: The standard clinical protocol of image-guided IMRT for prostate carcinoma introduces isocenter
relocation to restore the conformity of the multi-leaf collimator (MLC) segments to the target as seen in the
cone-beam CT on the day of treatment. The large interfractional deformations of the clinical target volume (CTV)
still require introduction of safety margins which leads to undesirably high rectum toxicity. Here we present further
results from the 2-Step IMRT method which generates adaptable prostate IMRT plans using Beam Eye View (BEV)
and 3D information.
Methods: Intermediate/high-risk prostate carcinoma cases are treated using Simultaneous Integrated Boost at the
Universitätsklinkum Würzburg (UKW). Based on the planning CT a CTV is defined as the prostate and the base of
seminal vesicles. The CTV is expanded by 10 mm resulting in the PTV; the posterior margin is limited to 7 mm. The
Boost is obtained by expanding the CTV by 5 mm, overlap with rectum is not allowed. Prescription doses to PTV
and Boost are 60.1 and 74 Gy respectively given in 33 fractions.
We analyse the geometry of the structures of interest (SOIs): PTV, Boost, and rectum, and generate 2-Step IMRT
plans to deliver three fluence steps: conformal to the target SOIs (S0), sparing the rectum (S1), and narrow segments
compensating the underdosage in the target SOIs due to the rectum sparing (S2). The width of S2 segments is
calculated for every MLC leaf pair based on the target and rectum geometry in the corresponding CT layer to have
best target coverage. The resulting segments are then fed into the DMPO optimizer of the Pinnacle treatment
planning system for weight optimization and fine-tuning of the form, prior to final dose calculation using the
collapsed cone algorithm.
We adapt 2-Step IMRT plans to changed geometry whilst simultaneously preserving the number of initially planned
Monitor Units (MU). The adaptation adds three further steps to the previous isocenter relocation: 1) 2-Step
generation for the geometry of the day using the relocated isocenter, MU transfer from the planning geometry;
2) Adaptation of the widths of S2 segments to the geometry of the day; 3) Imitation of DMPO fine-tuning for the
geometry of the day.
Results and conclusion: We have performed automated 2-Step IMRT adaptation for ten prostate adaptation cases.
The adapted plans show statistically significant improvement of the target coverage and of the rectum sparing
compared to those plans in which only the isocenter is relocated. The 2-Step IMRT method may become a core of
the automated adaptive radiation therapy system at our department.
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For prostate cases, the clinical target volume (CTV) typic-
ally features large and random interfractional motions and
deformations due to filling in the neighboring rectum and
bladder [1-3]. Safety margins are introduced in the IMRT
protocols to account for these motions. The margins,
however, lead to undesirably high rectum toxicity [4]. The
direct compensation of CTV motion using IMRT in
combination with portal imaging devices (image-guided
IMRT) is the way to reduce safety margins and to allow
further dose escalation to the target and better sparing of
critical structures. Two main approaches to image-guided
IMRT are being pursued. As the relative movements in
the constellation prostate-rectum-bladder has been shown
to be patient-specific [2], one can accumulate patient sta-
tistics during the initial treatment fractions and use this
information to derive a patient-specific CTV associated
with reduced safety margins [5]. An alternative is the
aperture-based image-guided adaptation. Some authors
investigate the way to deform dose distributions [6] or in-
tensity maps [7,8] according to the beam eye view (BEV)
projections of structures of interest (SOIs) on the day of
treatment; the linear programming model is then solved
to translate dose distributions/intensity maps into adapted
multileaf collimator apertures (MLC segments). Others
propose to use the geometry of the day to directly restore
conformity of MLC segments to the target [9-12]. Al-
though the results of the latter studies are encouraging,
simply restoring the segment conformity to the target does
not account for the fundamental structure of IMRT plans.
The analysis of the roles of IMRT segments [13] led the
second author (KB) to propose a method of generating
adaptable IMRT plans, which was termed “2-Step segmen-
tation”. The associated set of adaptation rules was termed
“2-Step adaptation”. The first result of manual 2-Step
adaptation for the prostate patients followed [14].
In this paper we present the first result of the auto-
mated 2-Step adaptation of the IMRT plans. We start
with a brief recapitulation of the principles of 2-Step
adaptation. The adaptation to the changed geometry of
the QUASIMODO phantom [15] is considered for illus-
trative purposes. Then the adaptation results for the
prostate patients in the experimental environment
closely resembling that of [14] are presented, discussed,
and conclusions are drawn.
Methods
The treatment planning system (TPS) Pinnacle3™ version
9.2 (Philips, Fitchburg, WI) was used in the present
study for all dose calculations and plan optimisations.
The Elekta Synergy S™ linac (Elekta AB, Stockholm,
Sweden) with the multileaf collimator (MLC) with 4 mm
leaves (BeamModulator™) has been commissioned in the
TPS.2-Step adaptation illustrated using QUASIMODO und
prostate case
As was discussed in [16], the adaptation methods which
preserve Monitor Units (MU) of MLC segments constant
have a number of advantages. These methods assume that
the interfractional geometry change is “small enough”, so
that the segments may retain their original MUs and only
their form needs to be adapted. The definition of “small”
is not available beforehand, and has to come from prac-
tical experience. The introduced dose inhomogeneities
can be compensated by additional shifts of MLC leaves. In
principle, for any given number of MUs we can improve
the homogeneity of the plan by shifting the MLC leaves,
unless the interfractional geometry change is so large that
under the condition of MU preservation there is no chance
to arrive at a clinically acceptable plan. For quality assur-
ance purposes, due to fewer degrees of freedom the plans
adapted under MU preservation require fewer dosimet-
ric pre-treatment checks than the plans resulting from
MU-modifying adaptation. In conclusion, MU-preserving
adaptation is an appropriate starting point in the develop-
ment of any general adaptation technique.
The fundamental principles of generation of 2-Step
IMRT plans are reviewed in the Appendix A; the refer-
ences to the relevant literature are provided therein. It has
been shown in a number of publications [13,14] that
2-Step IMRT plans intrinsically allow MU-preserving
ad-hoc geometric adaptation due to clear functional classi-
fication of segments. The adaptation rules have been
described in detail in earlier publications [13,14,17]. We il-
lustrate them here briefly using the QUASIMODO phan-
tom and the prostate cancer case.
The QUASIMODO phantom was introduced to com-
pare coplanar IMRT techniques across institutions [15]. It
represents a prostate cancer case with virtually no vertical
change, but quite challenging in axial plane due to almost
fully enclosed target. QUASIMODO geometry is also ad-
vantageous since it is close to the ideal geometry consid-
ered in [18] and [13]. Let’s consider two QUASIMODO
geometries, planning geometry (CT1), and geometry of
the day (CT2), where the target extends inwards from
CT1 to CT2, and the gap γ between the target and the
OAR remains constant, see Figure 1. The difference of
the normalized OAR radii Δρ = |ρOAR, CT1 − ρOAR, CT2|
is chosen to be of the order of 5%, which results in a 2%
difference between planned MUs for the two geometries.
According to our experience, such MU difference is typ-
ical for the interfractional geometry changes observed for
prostate patients.
For the adaptation from CT1 to CT2, we want to
achieve the target coverage not significantly worse than
the coverage from the native CT2 plan. We build on the
standard clinical protocol and relocate the isocenter of
the native CT1 plan to have maximum target coverage
S1 S2
1. MU transfer
2. Adaptation of S2 width
CT1
CT2
CT1
Figure 1 Adaptation of S2 width. Top – the CT1 plan applied “as is” underdoses inner areas of the CT2 target; middle – new 2-Step segments
overdose the CT2 target under MU preservation; bottom – adaptation of S2 width restores required target coverage under MU preservation. The
light-green line shows D95% isodose.
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phantom, where the necessary shift from CT1 to CT2 is
zero by definition, but becomes important for real clinical
cases. For the QUASIMODO phantom, the native CT1
plan relocated to CT2 underdoses inner areas of the target
(Figure 1, top) which is reflected in the corresponding
DVH, see Figure 2, left. Apparently, the segments need to
follow the inward movement of the OAR edge. After new
2-Step segments are generated for CT2 and the MUs are
transferred from CT1 (Figure 1, middle), the dose gradient
moves back into the gap between the OAR and the target,
but the target is overdosed (Figure 2, left, adaptation step
1). It has been shown [13] that one can restore the re-
quired target coverage under the condition of MU preser-
vation if one additionally adapts the width of the narrow
S2 segment to the changed geometry according to
βCT2 ¼ βCT1⋅
β;adaptγCT2 ρOAR;CT2
 
β;adaptγCT1 ρOAR;CT1
  ð1Þwhere β;adapt :¼ ωadaptopt ⋅βadaptopt , ωadaptopt ; βadaptopt
h i
is the pair
of normalized weight and width of the S2 segment which
optimally restores required target coverage, minimizing
objective function (A.1), see Appendix A, under the con-
dition of MU preservation, ωCT2 = ωCT1. The quantity
β;adaptγ ρOAR
 
was measured on alternating geometries
of the QUASIMODO phantom for different normalized
gaps γ and normalized OAR radii ρOAR, and parameter-
ized using a polynomial of the fourth order [14,16]. This
parameterization can be used to adapt S2 width of the
day, βCT1, to the new geometry in every CT layer, as-
suming MU preservation, ωCT2 = ωCT1.
The result of adaptation of the S2 width is shown in
Figure 1, bottom. According to [14], decreased OAR
radius requires narrower S2 segments to remove the
overdosage and restore required target coverage. The
corresponding improved DVH is shown in Figure 2, left,
adaptation step 2.
Having considered the idealized QUASIMODO phan-
tom, we now move on to consider a clinical prostate cancer
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Figure 2 2-Step adaptation for the QUASIMODO case (left) and for the real clinical case of prostate cancer treatment (right). Thin
dashed line – native CT1 plan applied to the CT2 geometry (relocated plan for the clinical case), thin solid line – native plan for the CT2
geometry (“golden standard”). The numbers denote adaptation steps. For the QUASIMODO case two adaptation steps are shown: 1. Generation
of the 2-Step segments for the CT2 geometry with MUs transferred from the CT1 plan; 2. Adaptation of S2 widths according to (1). For the real
clinical case additional step is performed: 3. Imitation of DMPO shifts for CT2 segments.
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segments for CT2. In this way we ensure that approxi-
mately the same part of the BEV is used to irradiate the
target in CT1 and in CT2, and the adverse effect of non-
flatness inherent in the clinical beam profile is minimized.
In Figure 2, right, the DVHs for the real prostate case
are shown. Boost and PTV − Boost are the target SOIs,
their exact definition is explained in the next section.
For now, it is important to have them both adequately
covered, ideally approaching the “golden standard” of
the native CT2 plan. Again, we consider the geometric
difference between two CTs to be “small”, resulting in 1)
a small difference between planned MUs, on the order
of one per cent; 2) a similar 2-Step segment sets for the
two geometries, with approximately the same number of
2-Step segments of each type. In Figure 2, right, adapta-
tion step 1 corresponds to the 2-Step plan generated for
the CT2 geometry with MUs transferred from the corre-
sponding segments of the CT1 geometry. Adaptation
step 2 shows the result of the adaptation of the widths
of S2 segments. For each MLC leaf pair we find a corre-
sponding CT slice, measure target and OAR radii and
the OAR-target gap as projected in BEV, and calculate
normalized values ρOAR and γ to be used in (1). As we
see, the result for the Boost is quite encouraging, but
not for the PTV − Boost.
Hitherto the deformations of the target SOIs (expan-
sion/contraction, rotations) have been taken into ac-
count via the forward planning for CT2. However, the
MUs found for CT1 segments cannot be separated from
the features of the geometric form introduced by
DMPO into CT1 segments. These features are imitated
for CT2 segments, see Figure 3. We consider CT1 and
store the shifts of the MLC leaves introduced to pre-
DMPO 2-Step segments (Figure 3, top left) at theDMPO optimization stage (Figure 3, top right ). Then
we consider CT2, find a corresponding pre-DMPO 2-
Step segment (Figure 3, bottom left), and shift the MLC
leaves the same distance and direction (Figure 3, bottom
right). The changed vertical extension of the target is
taken into account to have approximately the same por-
tion of the BEV projection of the target exposed/spared
in CT2 and CT1. The resulting adapted plan (Figure 2,
right, adaptation step 3) provides target coverage im-
proved over the relocated plan for both target SOIs.
To summarize, 2-Step adaptation adds three further
steps to the standard clinical protocol of isocenter
relocation:
1) 2-Step generation for the geometry of the day using
the relocated isocenter, MUs are transferred from
the planning geometry;
2) Adaptation of S2 widths to the geometry of the day
for every MLC leaf pair according to (1). Normalized
OAR radius ρOAR and normalized OAR-target gap γ
are measured in the corresponding CT layer;
3) Imitation of DMPO fine-tuning for the geometry of
the day.
2-Step adaptation: intermediate/high risk prostate
carcinoma
Intermediate/high-risk prostate carcinoma cases are treated
at UKW using Simultaneous Integrated Boost (SIB) [19].
Based on planning CT, a CTV is defined as the prostate
and the base of seminal vesicles. The CTV is expanded by
10 mm resulting in the PTV, the posterior margin is limited
to 7 mm. The Boost is obtained by expanding the CTV by
5 mm, overlap with rectum is not allowed. Prescription
doses to PTV and Boost are 60.1 and 74 Gy respectively,
given in 33 fractions [20].
Figure 4 The BEV view of the SOIs.
OAR OAR
OAROAR
Target Target
DMPO
DMPO imitationTarget Target
CT1
CT2
Figure 3 DMPO imitation: the DMPO fine-tuning for CT1 (blue arrow – sparing, red arrow – exposure) is imitated for CT2, taking
changed vertical extension of the target into account.
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house C++ software and fine-tuned in DMPO™ module
of Pinnacle™ 9.2 in 25 optimization steps using a
composite objective value (COV) as a function to be
minimized. The COV is the sum of all weighted object-
ive values. Objective values were defined as volume-
normalized quadratic penalties referred to points in
the dose volume histograms (DVHs). Typically four
objectives were used for the PTV: two objectives de-
scribed the requirements near the minimal dose and
two near the maximal dose. Three objectives were used
for the Boost in an analogous manner. For the rectum
four objective values described the desired course of
the DVH. No constraints were set for the optimization,
rather objectives were appropriately weighted: the weights
for the objectives were chosen in a wide range from 0.1
(i. e. for the shells of healthy tissue surrounding the PTV)
to 100 (i. e. for PTV dose minima). The BEV view of
the SOIs for the gantry at around 270° is shown in
Figure 4. The set of pre-DMPO segments for Boost and
PTV is shown in Figure 5, top. The same segments after
DMPO fine-tuning are shown in Figure 5, bottom.
Patients were advised to have an empty bowel and a full
bladder for the planning CT and during the treatment. For
cone-beam CT (CBCT) of the day, the standard clinical
protocol based on the soft tissue/bony anatomy alignment
is applied. The patient is relocated to achieve maximal
overlap between the PTV/Boost and the prostate as seen
in the CBCT image. The rectum and the bladder should
remain reasonably spared. In approximately 2% of cases
the matching between the planning and daily structures is
unsuccessful, and the patients are sent to undergo a re-
peated planning CT. The SOIs are always contoured by
the same attending physician according to well predefinedrules. All clinical CTs are reconstructed with a voxel size
of 1 mm in-plane and 2.5 mm slice thickness.
Five intermediate/high-risk prostate carcinoma patients
for which it was not possible to match the planning SOIs to
the CBCT image on the day of treatment were selected for
the present study. In the following, CT1 refers to the ini-
tial planning CT, CT2 refers to the repeated planning CT.
In this work we adapted both PTV and Boost seg-
ments to be able to adequately compare the dose distri-
butions of the adapted plans and the native plans using
our standard clinical protocols. A specific example of
segment adaptation is shown in Figure 6. Figure 6, left,
shows the S0 segment for the PTV from Figure 5, a,
fine-tuned for CT1. Figure 6, middle, shows the same
Figure 5 The pre-DMPO (top) and DMPO fine-tuned segments (bottom) oriented at the PTV (a-c) and at the Boost (d-f).
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segment extends too much vertically and underexposes
the PTV too much on the right. The vertical extension
is taken into account at 2-Step generation, the geometric
features from DMPO are re-introduced by DMPO imita-
tion; the adapted segment is shown in Figure 6, right.
Another specific example is shown in Figure 7, now for
the S2 type segment from Figure 5, f, oriented at the
Boost. Again, the geometric features of the segment edge
adjacent to the rectum are re-introduced at DMPO imita-
tion phase. The leaf openings are adapted to the changed
3D geometry in the corresponding CT layer: the rectum
radius decreases in almost all CT layers, and leaf openings
correspondingly decrease according to (1) and [14].
Results
The dose distributions for all native, relocated, and
adapted plans were calculated in Pinnacle3™. The evalu-
ation of the obtained dose distributions was then per-
formed. We measured target coverage using D99% in the
CTV and the quality score SD. The quality score SD was
introduced by the QUASIMODO group to compare dif-
ferent plans against the same dose objectives [15]. For
our purposes SD sums up violations of dose require-
ments for Boost and PTV − Boost:Figure 6 Adaptation example: left – S0 segment for the PTV, fine-tun
relocation; right – corresponding adapted segment.SD ¼ ∑
j
Aj −Rj lo
 ; if Aj < Rj lo
Aj −Rj up
 ; if Aj > Rj up
0; if Rj lo ≤Aj ≤Rj up
ð2Þ
8><
>:
where Aj are achieved dose values, Rj lo/up is the lower
(upper) limit of the required dose range.
The following parameters characterized the course of
the Boost DVH: Dmean, D99%, D95%, D1%; of the PTV −
Boost DVH: D99%, D95%. The dose ranges required for
native plans can be found in Table 1. The plan which
fulfils all requirements has SD = 0. To evaluate dose load
to the rectum we used absolute rectum volumes defined
by the respective 50%, 80%, and 95% isodoses.
The change of the prostate volume between treatment
fractions observed by [12] was 5-10%; only once did the
authors observe a change of 20%. In Figure 8, left, and
Table 1 we show the result of the adaptation for the case
of the least volumetric difference between target SOIs in
CT1 and CT2 which we observed, of the order of 5%;
the corresponding difference between the MUs for the
native plans is around 2%. Figure 8, left, presents the
DVHs for relocated, native, and adapted plans. The vis-
ual comparison of the DVHs shows the improvement of
the adapted plan against the relocated plan, both ined for CT1; middle – the same segment in CT2 after isocenter
Figure 7 Adaptation example: left – S2 segment for the Boost, fine-tuned for CT1; middle – the same segment in CT2 after isocenter
relocation; right – corresponding adapted segment.
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of DVH evaluation are shown in Table 1. The required
dose values, achieved dose values, and the corresponding
SD calculated according to (2) are shown for relocated,
native, and adapted plans. The improvement of the tar-
get coverage is reflected by the drop of SD for the
adapted plan against the relocated plan from 19.1 to
7.4 Gy. The D99% for the CTV DVH increases corres-
pondingly. The rectum sparing for the adapted plan
considerably improves against the relocated plan, as
V95% and V80% values indicate.
The adaptation result for the case with the largest volu-
metric difference between target SOIs in CT1 and CT2 is
shown in Figure 8, right. Due to increased bladder andTable 1 Evaluation for the case of the least volumetric differe
(DVHs in Figure 8, left)
Required Relocat
MUs 493
CTV D99% [Gy] 62.7
achieved
Boost
Dmean [Gy] 76.2 ± 1%: 75.5
[75.4, 77.0]
D99% [Gy] >70 64.3
D95% [Gy] 74 ± 2%: 69.1
[72.5, 75.5]
D1% [Gy] <80 79.6
PTV − Boost
D99% [Gy] >56 48.3
D95% [Gy] 60.1 ± 2%: 56.5
[58.9, 61.3]
Net SD
Rectum
V95% [cm
3] 2.8
V80% [cm
3] 9.1
V50% [cm
3] 26.1rectum filling in CT2 (Figure 9, top), the prostate is pushed
down and the seminal vesicles are compressed between
the bladder and the rectum. Consequently, the upper part
of the PTV which encloses the base of the seminal vesicles
extends further up in CT2 compared to CT1, and the
Boost shrinks from 89 to 70 cm3, by 25%, as compared to
much more moderate difference of Boost volumes for
other patients, of the order of several percent. Additionally,
the rectum folds in some CT2 layers in (Figure 9, bottom).
As a result, the plans optimized for native geometries re-
quire 697 and 593 MUs, with the difference of the order of
15%, as compared to the difference of the order of 2% for
other four patients. As DVHs in Figure 8, right, and corre-
sponding evaluation in Table 2 show, the result of thence between target SOIs in CT1 and CT2
ion Native Adapted
502 493
64.3 68.7
SD achieved SD achieved SD
0 - - 76.1 0
5.7 71.3 0 68.2 1.8
3.4 73 0 71.3 1.2
0 79.1 0 81.9 1.9
7.6 58.9 0 53.6 2.4
2.4 61.4 0.1 58.8 0.1
19.1 0.1 7.4
1 0.1
9.1 5
27.8 27.2
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Figure 8 Adaptation for the least (left), and the largest (right) volumetric difference between target SOIs in CT1 and CT2: DVHs for
relocated (thin dashed), native (thin solid), and adapted (thick solid) plans.
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coverage gets even worse: SD for the adapted plan in-
creases against the relocated plan from 31.5 to 36.8 Gy;
however, rectum sparing improves considerably.
Two CTs per case provide two adaptation directions,
from CT1 to CT2 (“forward”) and from CT2 to CT1
(“backward”). We considered “forward” and “backward”Figure 9 The prostate case of the largest volumetric difference betwe
bottom – CT layers showing an effect of increased bladder and rectuadaptations as independent, so five patients provide ten
adaptation cases. Table 3 shows the target coverage
characterized by the SD value, and the dose load to the
rectum characterized by the V95% value for all ten cases.
According to Marzi et al. [21] V95% ≡V72,4Gy is highly
correlated with the NTCP of the late rectal bleeding. We
compared pairwise SD and V95% of adapted plans againsten target SOIs in CT1 (left) and CT2 (right): top – BEVs; middle,
m filling on Boost and PTV contours.
Table 2 Evaluation for the case of the largest volumetric difference between SOIs in CT1 and CT2 (DVHs in Figure 8, right)
Required Relocation Native Adapted
MUs 697 593 697
CTV D99% [Gy] 81.7 75 76.4
achieved SD achieved SD achieved SD
Boost
Dmean [Gy] 76.2 ± 1%: 83.3 6.3 - - 82.5 5.5
[75.4, 77.0]
D99% [Gy] >70 78.7 0 73 0 75.3 0
D95% [Gy] 74 ± 2%: 80.5 5.0 74.2 0 77.2 1.7
[72.5, 75.5]
D1% [Gy] <80 86.1 6.1 78.5 0 90.1 10.1
PTV − Boost
D99% [Gy] >56 46.4 9.6 58 0 44 12
D95% [Gy] 60.1 ± 2%: 54.4 4.5 59.7 0 51.4 7.5
[58.9, 61.3]
Net SD 31.5 0 36.8
Rectum
V95% [cm
3] 14 1.7 1
V80% [cm
3] 24.5 13.2 7.5
V50% [cm
3] 58.3 46.6 35.3
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against relocated, using 1-tail Wilcoxon signed rank test.
The resulting Wilcoxon probabilities are shown in
Table 4. As one can see, adapted plans provide a signifi-
cant improvement (Wilcoxon p < 0.05) of both the target
coverage and the rectum sparing against relocated plans.
Discussion
The prostate case with large volumetric difference between
CTs, and, correspondingly, with large MU difference be-
tween native plans, of the order of 15%, deserves specialTable 3 The SD and rectum V95% values for ten
adaptation cases
Case SD ,Gy V95%, cm
3
Relocated Native Adapted Relocated Native Adapted
1 74.1 17.8 41.1 2.8 0.2 0.1
2 63.1 5.4 5.1 14 0.6 2.9
3 19.2 5.7 13.4 4.4 2.4 4.5
4 19.1 0.1 7.4 2.8 1 0.1
5 45.2 0 5.3 0 1.4 3
6 31.5 0 36.8 14 1.7 1
7 67.8 1 9.6 2 2.7 0.1
8 83.3 0 17.1 7.3 1.8 3.3
9 23.5 0,5 11.5 17.7 6 4.3
10 69.8 0 24.5 0.2 2.4 0.4attention. Figure 10, left, reproduces the result from
Figure 8, right. Figure 10, right, shows for comparison the
result of the adaptation in the opposite direction, from
CT2, Figure 9, right, to CT1, Figure 9, left. The adaptation
in the opposite direction produces a plan with much better
target coverage characterized by the drop from SD =
45.2 Gy to SD = 5.3 Gy, but marginally acceptable rectum
sparing characterized by V95% = 3 cm3. So either target
coverage or rectum sparing is compromised after forward
or backward adaptation. This case gives an indication of
“large” interfractional geometry difference: volumetric dif-
ferences on the order of 25% (MU difference on the order
of 15%) are likely to bring the 2-Step adaptation method to
its limits. Such large interfractional differences are, how-
ever, expected to be rare in clinical practice [12]. For such
cases the extension to MU-modifying adaptation seems to
be necessary [16].Table 4 The results of the 1-tail Wilcoxon signed rank test
for SD and rectum V95% from Table 3, different plan
groups are compared (see text for explanation)
Wilcoxon p
SD V95%
Adapted against relocated 0.0037* 0.0314*
Native against adapted 0.0037* 0.4483
Native against relocated 0.0027* 0.0250*
(*) marks significant difference (p < 0.05).
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Figure 10 Adaptation for the case of the largest volumetric difference between target SOIs in CT1 and CT2: forward direction (left)
and backward direction (right). Either target coverage or rectum sparing is compromised after adaptation.
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The present work reminds the reader the principles of the
2-Step IMRT adaptation, for the first time introduced in
[13], and manually applied to the prostate cases in [14].
The 2-Step IMRT adaptation to the changed geometry
of the QUASIMODO phantom has been considered for
illustrative purposes. The automated 2-Step IMRT adap-
tation for ten prostate carcinoma adaptation cases has
been performed. The adapted plans show statistically
significant improvement (Wilcoxon 1-tail p < 0.05) of
the target coverage and of the rectum sparing against
the relocated plans.
This paper provides present status of the on-going work
towards developing an adaptive radiation therapy (ART)
system at UKW. Next, the potential margin reduction has
to be investigated. Monitoring of delivered fraction dose
has to be implemented, e.g. using post-fraction summation
of the dose distributions based on the non-rigid registra-
tion; this would allow falling back to complete re-planning
in the case of threatening rectum overdosage or target
underdosage. The standalone DICOM-aware adaptation
system is planned to be developed, supplemented by the
efficient quality assurance system for ART plans.Figure 11 S1 and S2 fluence steps (left) which produce approximatel
represents the ideal dose distribution). Conformal S0 step defines the oAppendix
Appendix A. 2-Step segmentation
The principle behind 2-Step segmentation stems from the
fundamental work of Brahme [18] and is described in detail
elsewhere [22]. In short, it uses geometric analysis of struc-
tures of interest to generate segments which deliver three
fluence steps: conformal to the target (Step 0, “S0”), sparing
the OAR (Step 1, “S1”), and narrow segments compensating
for the underdosage in the target due to OAR sparing (Step
2, “S2”). The width of the narrow S2 segments is calculated
for every MLC leaf pair based on the target and rectum
geometry in the corresponding CT layer to have best target
coverage as explained in [13].
Two blocked rotations which were subsequently summed
were considered, Figure 11. The resulting dose distribution
is the sum of the solutions for a single blocked rotation
discussed in [23]:
D ρOAR; β
gen; ρ
  ¼ D ρOAR; 1; ρ
 þ ω⋅D ρOAR; βgen; ρ
 
where ρ = r/RPTV is the normalized radial coordinate,
ρOAR = ROAR/RPTV is the normalized OAR radius, ω is the
weight of the second order blocking segment relative toy homogeneous dose distribution in the target (right, dotted line
verall dose level and is omitted for clarity.
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β =w/RPTV is the normalized width of the second order
blocking segment.
To find an optimal normalized width of the second
order blocking segment which best homogenizes the
dose distribution in the target, βopt, one has to minimize
the objective function
f 2 ¼ σ2D þ D−D0ð Þ2; ðA:1Þ
where D0 is the prescribed dose in the target, σD is the
root mean square of the dose distribution in the target. It
has been shown that the pair of optimal normalized
weight and width [ωopt, βopt] for the second order blocking
segment always exists, Figure 11, and the finding was that
the product ωopt ⋅ βopt ≡ β* depends only weakly on the
normalized target-OAR gap γ: β ¼ βγ ρOAR
 
. The set of
curves βγ ρOAR
 
was found analytically. It can be used to
find βopt for any geometry assuming ω = 1.
The 2-Step generation is a forward planning technique
and does not take detailed spatial relationship of the
organ constellation into account. Therefore it is followed
by the inverse planning Direct Machine Parameter
Optimization (DMPO) stage to fine-tune segment
shapes and weights. The DMPO essentially performs
second-order correction on top of the 2-Step segment
set. The equivalence of DMPO-fine-tuned 2-Step IMRT
plans and conventional IMRT plans, for example as real-
ized by the DMPO™ module of Pinnacle™, has been
shown in earlier publications [24].
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